IN2004DN03762A - - Google Patents
Download PDFInfo
- Publication number
- IN2004DN03762A IN2004DN03762A IN3762DEN2004A IN2004DN03762A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A IN 3762DEN2004 A IN3762DEN2004 A IN 3762DEN2004A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A
- Authority
- IN
- India
- Prior art keywords
- subjects
- dosing
- dose
- post
- subject
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Saccharide Compounds (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
A method of generating models with which to characterize selected aspects of the metabolic phenotype of subjects without dosing a test substance to those subjects or with which to predict, without dosing, the post-dose responses of subjects where those responses are dependent on metabolic phenotype, the method comprising: obtaining pre-dose data relating to a plurality of subjects before dosing with a dosing substance; obtaining post-dose data relating to the plurality of subjects after dosing with the dosing substance; and correlating inter-subject variation in the pre-dose data with inter-subject variation in the post-dose data, and generating a pre-to-post-dose predictive model on the basis of the observed correlation. The models may be used to determine selected aspects of the metabolic phenotype of a subject or to predict, without dosing, the post-dose responses of subjects. This is achieved by analysing data relating to the un-dosed subject in relation to a model describing the correlation of pre-dose and post-dose data relating to a plurality of subjects when dosed with a particular substance which challenges the biochemical transformation or pathway of interest; and generating, according to the predetermined criteria of the model, a numerical measure or classification describing the metabolic phenotype of the un-dosed subject.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0213786A GB0213786D0 (en) | 2002-06-14 | 2002-06-14 | Metabolic phenotyping |
| GB0213895A GB0213895D0 (en) | 2002-06-17 | 2002-06-17 | Metabolic phenotyping |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2004DN03762A true IN2004DN03762A (en) | 2010-01-08 |
Family
ID=29738094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3762DEN2004 IN2004DN03762A (en) | 2002-06-14 | 2003-06-16 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20050074745A1 (en) |
| EP (1) | EP1540560B1 (en) |
| JP (1) | JP4829496B2 (en) |
| KR (1) | KR20050012281A (en) |
| AT (1) | ATE502343T1 (en) |
| AU (1) | AU2003232406A1 (en) |
| CA (1) | CA2487836C (en) |
| DE (1) | DE60336403D1 (en) |
| HK (1) | HK1080167A1 (en) |
| HR (1) | HRP20041174A2 (en) |
| IL (1) | IL165329A0 (en) |
| IN (1) | IN2004DN03762A (en) |
| NO (1) | NO20045111L (en) |
| RU (1) | RU2004136317A (en) |
| WO (1) | WO2003107270A2 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050037515A1 (en) * | 2001-04-23 | 2005-02-17 | Nicholson Jeremy Kirk | Methods for analysis of spectral data and their applications osteoporosis |
| US20050130321A1 (en) * | 2001-04-23 | 2005-06-16 | Nicholson Jeremy K. | Methods for analysis of spectral data and their applications |
| CA2457432A1 (en) | 2001-08-13 | 2003-02-27 | Jan Van Der Greef | Method and system for profiling biological systems |
| ATE502343T1 (en) | 2002-06-14 | 2011-04-15 | Pfizer | METABOLIC PHENOTYPING |
| CA2536388A1 (en) * | 2003-08-20 | 2005-03-03 | Bg Medicine, Inc. | Methods and systems for profiling biological systems |
| WO2007050940A2 (en) * | 2005-10-27 | 2007-05-03 | Brandon Horn | Method for determining metabolic type |
| US7899625B2 (en) * | 2006-07-27 | 2011-03-01 | International Business Machines Corporation | Method and system for robust classification strategy for cancer detection from mass spectrometry data |
| ATE536425T1 (en) * | 2006-10-13 | 2011-12-15 | Metabolon Inc | BIOMARKERS ASSOCIATED WITH METABOLIC AGE AND METHODS OF USE THEREOF |
| US20080286774A1 (en) * | 2007-05-16 | 2008-11-20 | The Regents Of The University Of California | Real-time individualized therapy evaluation |
| US20100273203A1 (en) * | 2009-04-23 | 2010-10-28 | Board Of Trustees Of The University Of Arkansas | Methods and compositions for detecting metabolites |
| US8660823B2 (en) * | 2009-04-26 | 2014-02-25 | Lester F. Ludwig | Nonlinear and lie algebra structural analysis system for enzyme cascades, metabolic signal transduction, signaling pathways, catalytic chemical reaction networks, and immunology |
| GB0912685D0 (en) | 2009-07-22 | 2009-08-26 | Imp Innovations Ltd | Methods |
| GB0912744D0 (en) | 2009-07-22 | 2009-08-26 | Imp Innovations Ltd | Methods and uses |
| US8410064B2 (en) * | 2009-08-24 | 2013-04-02 | The Board Of Trustees Of The University Of Arkansas | Classical cannabinoid metabolites and methods of use thereof |
| US8883218B2 (en) * | 2010-03-26 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Anti-cancer nanoparticle compositions and methods of use |
| GB201012297D0 (en) * | 2010-07-22 | 2010-09-08 | Ge Healthcare Uk Ltd | A system and method for automated biological cell assay data analysis |
| US10161928B2 (en) * | 2010-07-26 | 2018-12-25 | Wellmetris, Llc | Wellness panel |
| US9095598B2 (en) | 2010-12-28 | 2015-08-04 | The Board Of Trustees Of The University Of Arkansas | Stilbenoid derivatives and their uses |
| US9535144B2 (en) | 2012-06-01 | 2017-01-03 | Liposcience, Inc. | NMR quantification of TMAO |
| US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| RU2533846C1 (en) * | 2013-05-13 | 2014-11-20 | Сергей Леонидович Устьянцев | Method for determining entropy in human or animal body |
| CN104215623B (en) * | 2013-05-31 | 2018-09-25 | 欧普图斯(苏州)光学纳米科技有限公司 | Laser Raman spectroscopy intelligence discrimination method and system towards conglomerate detection |
| US9953417B2 (en) | 2013-10-04 | 2018-04-24 | The University Of Manchester | Biomarker method |
| US9519823B2 (en) * | 2013-10-04 | 2016-12-13 | The University Of Manchester | Biomarker method |
| CN107764848A (en) * | 2016-08-18 | 2018-03-06 | 中国科学院烟台海岸带研究所 | A kind of method utilized based on metabolism group evaluation epinephelus feed |
| CN108766587B (en) * | 2018-05-11 | 2022-05-03 | 北京诺道认知医学科技有限公司 | Method and device for constructing drug administration database based on specified drugs |
| CN108717876B (en) * | 2018-05-11 | 2022-05-20 | 大连诺道认知医学技术有限公司 | Method and device for constructing drug administration database based on specified drugs |
| CN108445112B (en) * | 2018-05-29 | 2021-03-16 | 云南中烟工业有限责任公司 | Method for detecting 4- (N-methyl-N-nitrosamine) -1- (3-pyridyl) -butanone in tobacco smoke |
| WO2020081326A1 (en) * | 2018-10-15 | 2020-04-23 | Olaris, Inc. | Spectographic metabolite-signature for identifying a subject's susceptibility to drugs |
| EP4042224A4 (en) * | 2019-10-10 | 2023-11-08 | Georgia Tech Research Corporation | Label-free hematology and histopathology analysis using deep-ultraviolet microscopy |
| EP3809118B1 (en) * | 2019-10-17 | 2023-06-21 | Evonik Operations GmbH | Method of prediction a property value of a material using principal component analysis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6658396B1 (en) * | 1999-11-29 | 2003-12-02 | Tang Sharon S | Neural network drug dosage estimation |
| CA2416810A1 (en) * | 2000-07-28 | 2002-02-07 | Lion Bioscience Ag | Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal |
| ATE502343T1 (en) | 2002-06-14 | 2011-04-15 | Pfizer | METABOLIC PHENOTYPING |
-
2003
- 2003-06-16 AT AT03760097T patent/ATE502343T1/en not_active IP Right Cessation
- 2003-06-16 IL IL16532903A patent/IL165329A0/en unknown
- 2003-06-16 IN IN3762DEN2004 patent/IN2004DN03762A/en unknown
- 2003-06-16 CA CA2487836A patent/CA2487836C/en not_active Expired - Fee Related
- 2003-06-16 DE DE60336403T patent/DE60336403D1/en not_active Expired - Lifetime
- 2003-06-16 RU RU2004136317/15A patent/RU2004136317A/en not_active Application Discontinuation
- 2003-06-16 JP JP2004514009A patent/JP4829496B2/en not_active Expired - Fee Related
- 2003-06-16 KR KR20047020355A patent/KR20050012281A/en not_active Application Discontinuation
- 2003-06-16 EP EP03760097A patent/EP1540560B1/en not_active Expired - Lifetime
- 2003-06-16 AU AU2003232406A patent/AU2003232406A1/en not_active Abandoned
- 2003-06-16 WO PCT/IB2003/002309 patent/WO2003107270A2/en active Application Filing
-
2004
- 2004-01-08 US US10/755,061 patent/US20050074745A1/en not_active Abandoned
- 2004-11-24 NO NO20045111A patent/NO20045111L/en not_active Application Discontinuation
- 2004-12-09 HR HR20041174A patent/HRP20041174A2/en not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100119.0A patent/HK1080167A1/en unknown
-
2008
- 2008-09-19 US US12/233,996 patent/US8577617B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE502343T1 (en) | 2011-04-15 |
| US20090192721A1 (en) | 2009-07-30 |
| EP1540560B1 (en) | 2011-03-16 |
| US20050074745A1 (en) | 2005-04-07 |
| HK1080167A1 (en) | 2006-04-21 |
| WO2003107270A3 (en) | 2005-04-21 |
| EP1540560A2 (en) | 2005-06-15 |
| WO2003107270A2 (en) | 2003-12-24 |
| IL165329A0 (en) | 2006-01-15 |
| NO20045111L (en) | 2005-01-12 |
| US8577617B2 (en) | 2013-11-05 |
| DE60336403D1 (en) | 2011-04-28 |
| KR20050012281A (en) | 2005-01-31 |
| AU2003232406A1 (en) | 2003-12-31 |
| CA2487836A1 (en) | 2003-12-24 |
| JP2005534899A (en) | 2005-11-17 |
| RU2004136317A (en) | 2006-01-27 |
| JP4829496B2 (en) | 2011-12-07 |
| CA2487836C (en) | 2014-12-02 |
| HRP20041174A2 (en) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1080167A1 (en) | Metabolic phenotyping | |
| BRPI0507858A (en) | smooth drag for forming pressure test | |
| Alexander et al. | Variations with age in the mechanical properties of human skin in vivo. | |
| WO2006133149A3 (en) | Method for analyzing power consumption of circuit design using hardware emulation | |
| GB2468045A (en) | Method for reservoir characterization and monitoring including deep reading quad combo measurements | |
| RU2008144430A (en) | METHOD AND SYSTEM FOR RECEIVING COSMETIC PRODUCTS TO ORDER | |
| ATE431097T1 (en) | METHOD AND DEVICE FOR ANALYZING A LIQUID | |
| ATE509580T1 (en) | METHOD FOR DETECTING AND PREDICTING OVULATION AND FERTILE PERIOD | |
| RU2013114331A (en) | METHODS AND SYSTEMS FOR ESTIMATING PSYCHOLOGICAL CHARACTERISTICS | |
| WO2007020598A3 (en) | Method and apparatus featuring simple click style interactions according to a clinical task workflow | |
| CN109918833A (en) | A kind of quantitative analysis method of numerical simulation confidence | |
| Welty et al. | Metrology for AI: From benchmarks to instruments | |
| Désenfant et al. | Road map for measurement uncertainty evaluation | |
| BR122017010425B8 (en) | method of producing a measurement of an analyte using a test strip | |
| GB201015230D0 (en) | A method and system for managing analytical quality in networked laboratories | |
| Klauenberg et al. | Bayesian glaciological modelling to quantify uncertainties in ice core chronologies | |
| Savić et al. | Metrological traceability of a system for measuring electrodermal activity | |
| WO2007136848A3 (en) | Interactive device for monitoring and reporting glucose levels | |
| Popescu et al. | Relations between learning style and learner behavior in an educational hypermedia system: An exploratory study | |
| Odenwald | Test methods in the development of sports equipment | |
| WO2008051660A3 (en) | Apparatus and method for computer modeling chemical sensitivity of skin | |
| WO2008157566A3 (en) | Computerized evaluation of user impressions of product artifacts | |
| Dale | What is the best model for estimating joint health states utilities? Comparing the linear index model to the proportional decrement model | |
| Walker | Estimating how many observations are needed to obtain a required level of reliability | |
| Corfield | Description, dueting, seasonal variations, and individual identification of the vocalisations of the Brown Kiwi (Apteryx mantelli) |